CANIMGUIDE THERAPEUTICS
CanImGuide is developing a therapeutic platform based around an extraordinary biologic concept and an entirely new mechanism of action for immunomodulation. They have discovered and thoroughly demonstrated, that a previously unknown immunosuppressive peptide named P3028 is formed in malignant tumors through the breakdown of albumin. This intra-tumoral albumin peptide binds to the fundamental receptor.
CANIMGUIDE THERAPEUTICS
Social Links:
Industry:
Therapeutics
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.canimguide.com
Status:
Active
Contact:
+46 730 870 660
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Current Advisors List
Official Site Inspections
http://www.canimguide.com Semrush global rank: 5.92 M Semrush visits lastest month: 1.39 K
Unable to get host informations!!!
More informations about "CanimGuide Therapeutics"
CanimGuide Therapeutics - Crunchbase Company Profile & Funding
CanImGuide is developing a therapeutic platform based around an extraordinary biologic concept and an entirely new mechanism of action for immunomodulation. They have discovered and …See details»
CanimGuide Company Profile 2024: Valuation, Funding
CanimGuide General Information Description. Developer of novel peptides intended to provide treatment for cancer. The company's peptides inhibit the activity of an immunosuppressor …See details»
CanImGuide Therapeutics AB - VentureRadar
CanImGuide is a company with a novel, simple but sophisticated and highly innovative, peptide approach to immuno-oncology.CanImGuide has founded a subsidiary company to focus …See details»
CanImGuide Therapeutics Information - RocketReach
CanImGuide Therapeutics AB is a private biopharmaceutical company developing immunology therapeutics with a novel, simple but sophisticated and highly innovative approach to …See details»
CanImGuide Therapeutics - Overview, News & Similar companies
Nov 28, 2018 Who is CanImGuide Therapeutics. CanImGuide Therapeutics AB is a private biopharmaceutical company developing immunology therapeutics with a novel, simple but …See details»
CanImGuide Therapeutics AB - Detailed information
CanImGuide Therapeutics AB. Contact. Business ID: 556700-2117 Company: CanImGuide Therapeutics AB Address: Box 4501 SE-203 20 Malmö Telephone: +46 (0)73-0870660 CFAR: …See details»
Canimguide Therapeutics AB - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Canimguide Therapeutics AB of Malmö, Skåne. Get the latest business insights from Dun & Bradstreet.See details»
CanImGuide Therapeutics AB - Drug pipelines, Patents, Clinical …
Explore CanImGuide Therapeutics AB with its drug pipeline, therapeutic area, technology platform, , Drug:P-28-R.See details»
CanimGuide Therapeutics - Tech Stack, Apps, Patents & Trademarks
CanimGuide Therapeutics is developing a therapeutic platform based around an extraordinary biologic concept.See details»
CanimGuide Therapeutics - Crunchbase
CanimGuide Therapeutics is developing a therapeutic platform based around an extraordinary biologic concept.See details»
CanImGuide Therapeutics - Company Profile - Tracxn
Oct 24, 2024 CanImGuide Therapeutics ranks 1,847th among 2363 active competitors. 849 of its competitors are funded while 549 have exited. Overall, CanImGuide Therapeutics and its …See details»
CanImGuide Therapeutics AB i Malmö – Info - Ratsit
Oct 6, 2024 CanImGuide Therapeutics AB - Org.nummer: 5567002117. Vid senaste bokslut 2023 hade företaget en omsättningsförändring på - 99.0%. På Ratsit hittar du Telefonnummer …See details»
CanImGuide Therapeutics AB - Företagsinformation - allabolag.se
CanImGuide Therapeutics AB,556700-2117 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för CanImGuide Therapeutics ABSee details»
CanImGuide Therapeutics - Products, Competitors, Financials, …
About CanImGuide Therapeutics. Developer of biotechnology for treating cancer. The company's current products include a test kit for assessing whether a patient will respond to a particular …See details»
CanimGuide Therapeutics - Contacts, Employees, Board Members, …
CanimGuide Therapeutics is developing a therapeutic platform based around an extraordinary biologic concept.See details»
Canimguide Therapeutics AB Malmö - Hitta.se
Hitta information om Canimguide Therapeutics AB. Företaget gick med förlust år 2023, omsättning 16 tkr. Sök namn, gata, ort, telefon, företag, sökord. Karta Alla kategorier …See details»
CANIMGUIDE THERAPEUTICS AB innovation strategy - GoodIP
CANIMGUIDE THERAPEUTICS AB has a total of 31 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in …See details»
CanImguide Therapeutics: New Discoveries in Cancer Related ...
Nov 28, 2018 CanImGuide Therapeutics AB is a private biopharmaceutical company developing immunology therapeutics with a novel, simple but sophisticated and highly innovative …See details»
P-28-R - Drug Targets, Indications, Patents - Synapse - Patsnap
Precise surgical resection directly influences the prognosis and survival of patients with solid tumors. However, it is often difficult to distinguish tumor from normal tissue during resection …See details»
Canimguide går i likvidation - Rapidus
Mar 6, 2023 Cancerforskningsbolaget Canimguide Therapeutics i Lund har valt att gå i likvidation. Genom åren har bolaget fått aktieägartillskott till ett värde av totalt cirka 100 …See details»